Tag:
Tesaro
Latest Headlines
Latest Headlines
Kleiner Perkins to back early-stage biotechs with $525M fund
Kleiner Perkins Caulfield & Byers has closed the books on a new $525 million fund. And a chunk of that treasure is earmarked for early-stage life science companies.
Tesaro promises rapid progress with cancer drugs in $86M IPO
Tesaro has put together an SEC filing that makes one essential promise to prospective investors: This company is built for speed.
Tesaro lands $101M B round as it preps for new cancer drug acquisitions
The veteran crew of cancer drug developers at MGI Pharma who went on to found Tesaro a little more than a year ago have rounded up a whopping $101 million B round led by Kleiner Perkins Caufield
MGI alum garner $60M to launch new cancer drug developer
A group of MGI Pharma alumni is launching a Boston-based startup named Tesaro in Boston with $60 million in venture backing for its plan to acquire, develop and commercialize new cancer drugs. The
